$AIP

JANAC K CHARLES sold $4.5M of AIP (indirect holdings)

JANAC K CHARLES (President and CEO) sold 125,976 indirectly-held shares of Arteris, Inc. (AIP) at an average of $35.79 ($35.06–$37.07, $4.51M total) across 3 trades on 2026-07-06 under a Rule 10b5-1 trading plan.

Original reporting
SEC EDGAR · JANAC K CHARLES
Published Jul 8, 2026, 8:16 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Jul 8, 2026, 8:21 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
AlphAI market briefInsider activity
Primary signal
$AIP
Neutral
high confidence
Mentioned
$AIP
Relevance
5/10
AlphAI data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$AIPNeutralLow
01

Why it matters

The newest disclosed fact is the $4.51M open-market sale of 125,976 shares at $35.0650 to $37.0705 on 2026-07-06 under a 10b5-1 plan.

02

Market read

Traders may monitor for sentiment effects, but there is no new guidance, deal, or operational catalyst in the text.

03

What to watch

The filing is indirect holdings, so the immediate signal about the CEO’s direct conviction may be weaker than a direct, non-10b5-1 sale.

Relevance 5/10Novelty 4/10Timing: after-hours filing timestamp 2026-07-08T16:16:11-04:00 for a 2026-07-06 sale

Background

The article is an SEC Form 4 insider transaction report for Arteris, Inc. (AIP) by CEO Janac K Charles.

Company-level read

Ticker impact

$AIPNeutralHigh confidence
Context

SEC Form 4 shows CEO Janac K Charles sold $4.51M of Arteris shares via a 10b5-1 plan on 2026-07-06.

Expected impact

Likely limited near-term impact; any effect would be sentiment-driven rather than earnings or guidance-related.

Evidence & confidence

The filing is a routine Form 4 transaction with stated 10b5-1 pre-arranged plan and no accompanying operational or financial guidance changes.

Market effects

No direct sector read-through; this is company-specific insider transaction disclosure.

None indicated.

None indicated.

Counterpoint

Because the sale is explicitly under a pre-arranged 10b5-1 plan, it may reflect scheduled liquidity needs rather than bearish expectations.

Key entities

  • Arteris, Inc.

    Subject of the Form 4 insider transaction disclosure.

  • JANAC K CHARLES

    President and CEO, reported indirect holdings sale under a 10b5-1 plan.

Full insider trading history

This story covers one filing. See everything behind it: every insider buy and sell on record, 10b5-1 plans, late filings, and which officers and directors are trading.

Related articles

$AIPMedAI 8/10

Arteris (AIP) Q2 2026 Earnings Call Transcript

Arteris, Inc. (AIP) reported Q2 2026 revenue of $24.1 million, up 46% year over year. ACV plus royalties were $99.5 million, up 44%, and remaining performance obligation was $135 million, up 36%. Cash and investments rose to $123 million after an at-the-market raise. Full-year 2026 revenue guidance was raised to $95-$98 million.

MedAI 8/10

Arteris Inc. raises FY26 sales guidance to $95-98M range

Arteris Inc. raised its FY2026 revenue guidance to $95.0 million to $98.0 million, up from $91.0 million to $95.0 million previously. The new range is above the $94.578 million analyst consensus estimate, reflecting stronger-than-expected demand for its NoC interconnects and design automation tools, according to the company.

$AIPHighAI 9/10

Arteris, Inc. (AIP): Results of Operations and Financial Condition

Arteris, Inc. (AIP) filed an SEC Form 8-K — Results of Operations and Financial Condition. Arteris Announces Financial Results for the Second Quarter and Estimated Third Quarter and Updated Full Year 2026 Guidance CAMPBELL, Calif. - August 6, 2026 - Arteris, Inc. (Nasdaq: AIP), a leading provider of semiconductor technology for accelerating innovation in the AI era, to